Vietnam well-positioned in world vaccine map

Vietnam well-positioned in world vaccine map hinh anh 1COVID-19 research (Photo: VNA)

Hanoi (VNA) – In recent years,
the ese health sector’s position has been increasingly affirmed thanks
to outstanding advances in research, development and application of technology
in many fields. In addition to achievements in laparoscopic surgery and organ
transplantation, Vietnam is also holding a rising important
position in the list of vaccine producers worldwide, according to
experts.

Vietnam has continuously implemented and
perfected the national immunisation system to prevent dangerous epidemics. Statistics
of the Ministry of Health show that there are currently about 30 infectious
diseases that can be prevented with vaccines.

More than 60 years ago, in the context of
difficulties posed by the war, Vietnam began producing the first vaccine – an
oral polio vaccine, as at that time the country recorded a high infection rate
of this disease.

Since 1990, the rate of under-one children receiving
three doses of polio vaccine had been maintained at over 90% and this was the
premise for the country to eradicate this disease in 2000.

Following the polio vaccine, Vietnam
developed an oral cholera vaccine, from technology transferred by Sweden. In
2000-2001, Vietnam continued to transfer this technology for free to a vaccine
institute in the Republic of Korea (RoK), and an Indian company then has had
the copyright to produce this vaccine for export around the world.

After that, Vietnam gradually proactively
produced many types of vaccines such as Hepatitis B vaccine from human plasma,
Japanese encephalitis vaccine, and diphtheria, pertussis and tetanus vaccine. In
2005, Vietnam produced and exported the first 1 million doses of Japanese
encephalitis vaccine to India and now the Vietnamese vaccine has been shipped to
other countries such as Timor-Leste, the RoK and Myanmar.

Since 2015, Vietnam has been one of nearly
40 countries to receive the National Vaccine Authority (NRA) Certificate from
the World Health Organisation (WHO) recognising its eligibility to export
vaccines to the world.

Just one year later, Vietnam marked an important milestone on the
when it produced its own high-quality combined
measles-rubella (MR) vaccine using Japanese technology. At this time, Vietnam
was one of 25 countries in the world and the fourth in Asia that can produce the
MR vaccine after Japan, India and China. Since April 2018, this vaccine has
been used on a national scale for children from 18 months old in the expanded immunisation
programme.

The year 2018 marked the next major
achievement of Vietnam’s health sector when successfully producing a 3-in-1
seasonal flu vaccine (A/H1N1/09, A/H3N2 and B) and pre-pandemic influenza A/H5N1
vaccine.

One of the outstanding achievements of the
sector in 2023 was that the Centre for Research and Production of Vaccines and
Biologicals (Polyvac) under the successfully exported 1
million doses of measles vaccine MVVac to India. Previously, the production technology
of this vaccine was transferred from Japan and it has been put into use in the
national expanded immunisation programme in Vietnam since 2009.

In February 2024, Vietnam had a new
generation vaccine to prevent meningitis caused by Neisseria meningitidis B.

In addition, Vietnam has also participated in the production and export of vaccines
for animals. In 2022, it was the first country to successfully research
and produce a vaccine to prevent African swine fever. In 2023, it officially
exported the African swine fever vaccine AVAC ASF LIVE to five countries, namey
Indonesia, the Philippines, Malaysia, Myanmar and India.

According to Ministry of Health Dao Hong Lan, Vietnam has made the best use of
advanced technology to produce vaccines to prevent human diseases, ensuring the
production of 11 out of 12 types of vaccines to serve the national expanded immunisation
programme.

In a speech at the 2023 National Scientific
Conference on medical research and application organised by the Vietnam General
Medical Association on October 12, 2023, Lan stressed that outstanding studies on vaccine
production and testing have made Vietnam a strong country in vaccine
production.

Vietnam eliminated neonatal tetanus in 2005
and is moving toward the goals of eliminating measles and reducing the rate of
hepatitis B infection in children under 5 years old to 1% in the near future./.

VNA

Source: VietnamPlus

Leave a Reply

Your email address will not be published. Required fields are marked *

14 Vu Trong Phung, Thanh Xuan, Ha Noi.

Hotline

Hotline

+84365999115

Email Us at

Email Us at

info@herac.org

Contact

Contact

Herac